AngioDynamics, Inc. (ANGO) vs Helus Pharma Inc. (HELP)

A side-by-side comparison of AngioDynamics, Inc. and Helus Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANGO vs HELP

growth of $100 · dividends reinvested · last 1y
ANGO +19.8% (+19.8%/yr)HELP +93.2% (+93.2%/yr)HELP compounded faster over this window
100150200250Start $1002026$120$193
ANGO HELP

ANGO vs HELP: by the numbers

  • •HELP is the larger company ($659M vs $620M market cap).
  • •HELP is profitable (329.09% net margin) while ANGO runs a net loss (-11.48%).

Metrics side by side

Valuation

MetricANGOHELP
P/S ratio1.94N/A
P/B ratio3.632.72
FCF yield0.08%N/A

Profitability

MetricANGOHELP
Gross margin54.62%100.27%
Operating margin-12.47%317.06%
Net margin-11.48%329.09%
ROE-21.51%-75.79%
ROIC-20.75%-73.27%

Growth (annualized)

MetricANGOHELP
Revenue CAGR (5Y)1.93%N/A
FCF CAGR (5Y)-51.49%N/A
Total return CAGR (5Y)-10.80%N/A

Frequently asked

Is ANGO or HELP more profitable?
HELP runs the higher net margin — ANGO at -11.48% versus HELP at 329.09%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.